RNA Enrichment Strategies for Low-Input Samples

Team Dynamic Matrices | 17 March 2026

Low-input RNA-seq, single cells, biopsies, liquid biopsy samples, amplifies every inefficiency in your enrichment method. Standard rRNA depletion or poly-A selection protocols, validated at microgram-scale input, frequently underperform when scaled down to picogram or low-nanogram quantities of starting material.

Why low input breaks standard protocols

The core problem is that many enrichment chemistries depend on hybridization kinetics or enzymatic efficiency that scales with concentration. At low input, reaction efficiency drops measurably, and what worked reliably at standard input leaves substantially more off-target material behind in the final library at low input.

Strategies that genuinely help

• Using enrichment chemistries less dependent on absolute concentration, such as sequence-specific capture mechanisms rather than mass-action hybridization that requires a minimum effective concentration to work efficiently.
       
• Minimizing the number of sample handling steps to reduce cumulative material loss, since every transfer and wash step in a low-input workflow removes a proportionally larger fraction of your limited starting material.
       
• Validating your specific method at your actual input range, rather than relying on manufacturer specifications generated from higher-input testing that may not reflect performance at your scale.

Why this matters most for clinical and diagnostic work

For diagnostic and clinical low-input applications specifically, this isn't a minor optimization detail, it's often the determining factor in whether a method is usable at all for a given sample type. A method that performs excellently at standard input but degrades sharply below a certain threshold may simply be the wrong tool for a liquid biopsy workflow, regardless of how well it's documented for other applications.